Marcin Wierzbicki

No ORCID on file · 1 paper in corpus · active 2023

Study types

  • article 1

Condition tags

  • endometriosis 1
article 2023
Next step in the development of mesoprogestins: the preclinical profile of EC313
Frontiers in endocrinology ·doi:10.3389/fendo.2023.1201547

Introduction The pharmacological target for progesterone, different progestins, and Selective Progesterone Receptor Modulators (SPRMs) is the nuclear progesterone receptor (PR). EC313 is a new member of a subgroup of SPRMs, mesoprogestins, …